Effect of pretransplant depression on neutrophil recovery following hematopoietic stem cell transplantation

References

• Ertas E, Kurnaz F, Zorba Y, et al. Comparison of chemotherapy and hematopoietic stem cell transplantation pre and postterm DMFT scores: a preliminary study. Niger J Clin Pract. 2014;17(1):32–37. doi:10.4103/1119-3077.122831
   Web of Science ®Google Scholar
• Barrett AJ, Battiwalla M. Relapse after allogeneic stem cell transplantation. Expert Rev Hematol. 2010;3(4):429–441. doi:10.1586/ehm.10.32
   PubMed Web of Science ®Google Scholar
• Costanzo ES, Juckett MB, Coe CL. Biobehavioral influences on recovery following hematopoietic stem cell transplantation. Brain Behav Immun. 2013;30:S68–S74. doi:10.1016/j.bbi.2012.07.005
   Web of Science ®Google Scholar
• Bacigalupo A, Sormani MP, Lamparelli T, et al. Reducing transplant-related mortality after allogeneic hematopoietic stem cell transplantation. Haematologica. 2004;89(10):1238–1247.
   Web of Science ®Google Scholar
• Porrata L, Markovic S. Timely reconstitution of immune competence affects clinical outcome following autologous stem cell transplantation. Clin Exp Med. 2004;4(2):78–85.
   Web of Science ®Google Scholar
• Gratwohl A. Risk assessment in haematopoietic stem cell transplantation. Best Pract Res Clin Haematol. 2007;20(2):119–124. doi:10.1016/j.beha.2006.10.011
   Google Scholar
• Appelbaum FR. The use of bone marrow and peripheral blood stem cell transplantation in the treatment of cancer. CA Cancer J Clin. 1996;46(3):142–164.
   Web of Science ®Google Scholar
• Hoodin F, Uberti J, Lynch T, Steele P, Ratanatharathorn V. Do negative or positive emotions differentially impact mortality after adult stem cell transplant? Bone Marrow Transplant. 2006;38(4):255. doi:10.1038/sj.bmt.1705419
   Google Scholar
• Loberiza FR Jr, Rizzo JD, Bredeson CN, et al. Association of depressive syndrome and early deaths among patients after stem-cell transplantation for malignant diseases. J Clin Oncol. 2002;20(8):2118–2126. doi:10.1200/JCO.2002.08.757
   Web of Science ®Google Scholar
• Kiecolt-Glaser JK, Glaser R. Methodological issues in behavioral immunology research with humans. Brain Behav Immun. 1988;2(1):67–78.
   PubMedGoogle Scholar
• Kiecolt-Glaser JK, Glaser R. Depression and immune function: central pathways to morbidity and mortality. J Psychosom Res. 2002;53(4):873–876.
   PubMed Web of Science ®Google Scholar
• Burns EA, Lum LG, Seigneuret MC, Giddings BR, Goodwin JS. Decreased specific antibody synthesis in old adults: decreased potency of antigen-specific B cells with aging. Mech Ageing Dev. 1990;53(3):229–241.
   Web of Science ®Google Scholar
• Costanzo ES, Sood AK, Lutgendorf SK. Biobehavioral influences on cancer progression. Immunol Allergy Clin North Am. 2011;31(1):109–132. doi:10.1016/j.iac.2010.09.001
   PubMed Web of Science ®Google Scholar
• Cavet J, Dickinson AM, Norden J, Taylor PR, Jackson GH, Middleton PG. Interferon-γ and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation. Blood. 2001;98(5):1594–1600.
   PubMed Web of Science ®Google Scholar
• Tegg E, Griffiths A, Lowenthal R, et al. Association between high interleukin-6 levels and adverse outcome after autologous haemopoietic stem cell transplantation. Bone Marrow Transplant. 2001;28(10):929. doi:10.1038/sj.bmt.1703272
   Web of Science ®Google Scholar
• Moylan S, Maes M, Wray N, Berk M. The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications. Mol Psychiatry. 2013;18(5):595. doi:10.1038/mp.2012.33
   PubMed Web of Science ®Google Scholar
• Dowlati Y, Herrmann N, Swardfager W, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010;67(5):446–457. doi:10.1016/j.biopsych.2009.09.033
   PubMed Web of Science ®Google Scholar
• Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med. 2009;71(2):171–186. doi:10.1097/PSY.0b013e3181907c1b
   PubMed Web of Science ®Google Scholar
• Tavakoli-Ardakani M, Mehrpooya M, Mehdizadeh M, Hajifathali A, Abdolahi A. Association between Interlukin-6 (IL-6), Interlukin-10 (IL-10) and depression in patients undergoing hematopoietic stem cell transplantation. Int J Hematol Oncol Stem Cell Res. 2015;9(2):80.
   Google Scholar
• Hill GR. Inflammation and bone marrow transplantation. Biol Blood Marrow Transplant. 2009;15(1):139–141. doi:10.1016/j.bbmt.2008.11.008
   Web of Science ®Google Scholar
• Takatsuka H, Takemoto Y, Yamada S, et al. Complications after bone marrow transplantation are manifestations of systemic inflammatory response syndrome. Bone Marrow Transplant. 2000;26(4):419. doi:10.1038/sj.bmt.1702517
   Web of Science ®Google Scholar
• Sjøqvist C, Snarski E. Inflammatory markers in patients after hematopoietic stem cell transplantation. Arch Immunol Ther Exp (Warsz). 2013;61(4):301–307. doi:10.1007/s00005-013-0228-z
   Web of Science ®Google Scholar
• Ghavamzadeh A, Alimoghaddam K, Ghaffari F, Derakhshandeh R, Jalali A, Jahani M. Twenty years of experience on stem cell transplantation in Iran. Iran Red Crescent Med J. 2013;15(2):93. doi:10.5812/ircmj.1915
   PubMed Web of Science ®Google Scholar
• Ghavamzadeh A, Alimoghaddam K, Jahani M, et al. Stem cell transplantation; Iranian experience. Arch Iran Med. 2009;12(1):69–72.
   Web of Science ®Google Scholar
• Montazeri A, Vahdaninia M, Ebrahimi M, Jarvandi S. The hospital anxiety and depression scale (HADS): translation and validation study of the Iranian version. Health Qual Life Outcomes. 2003;1(1):14. doi:10.1186/1477-7525-1-14
   PubMedGoogle Scholar
• El‐Jawahri A, Chen YB, Brazauskas R, et al. Impact of pre‐transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation. Cancer. 2017;123(10):1828–1838. doi:10.1002/cncr.30546
   PubMed Web of Science ®Google Scholar
• Grulke N, Larbig W, Kächele H, Bailer H. Pre‐transplant depression as risk factor for survival of patients undergoing allogeneic haematopoietic stem cell transplantation. Psycho-Oncology. 2008;17(5):480–487. doi:10.1002/(ISSN)1099-1611
   Web of Science ®Google Scholar
• Ehlers SL, Gastineau DA, Patten CA, et al. The impact of smoking on outcomes among patients undergoing hematopoietic SCT for the treatment of acute leukemia. Bone Marrow Transplant. 2011;46(2):285. doi:10.1038/bmt.2010.113
   Web of Science ®Google Scholar
• De Bock R, Middelheim A. Febrile neutropenia in allogeneic transplantation. Int J Antimicrob Agents. 2000;16(2):177–180.
   Web of Science ®Google Scholar
• Omrani AS, Almaghrabi RS. Complications of hematopoietic stem cell transplantation: bacterial infections. Hematol Oncol Stem Cell Ther. 2017;10(4):228–232. doi:10.1016/j.hemonc.2017.05.018
   Google Scholar
• Saito T, Kanda Y, Nakai K, et al. Immune reconstitution following reduced-intensity transplantation with cladribine, busulfan, and antithymocyte globulin: serial comparison with conventional myeloablative transplantation. Bone Marrow Transplant. 2003;32(6):601. doi:10.1038/sj.bmt.1704205
   Web of Science ®Google Scholar
• Mikulska M, Raiola AM, Galaverna F, et al. Pre-engraftment bloodstream infections after allogeneic hematopoietic cell transplantation: impact of t cell-replete transplantation from a haploidentical donor. Biol Blood Marrow Transplant. 2018;24(1):109–118. doi:10.1016/j.bbmt.2017.08.024
   PubMed Web of Science ®Google Scholar
• McGregor BA, Syrjala KL, Dolan ED, Langer SL, Redman M. The effect of pre-transplant distress on immune reconstitution among adult autologous hematopoietic cell transplantation patients. Brain Behav Immun. 2013;30:S142–S148. doi:10.1016/j.bbi.2012.07.020
   Web of Science ®Google Scholar
• Peggs KS, Mackinnon S. Immune reconstitution following haematopoietic stem cell transplantation. Br J Haematol. 2004;124(4):407–420.
   PubMed Web of Science ®Google Scholar
• Knight JM, Moynihan JA, Lyness JM, et al. Peri-transplant psychosocial factors and neutrophil recovery following hematopoietic stem cell transplantation. PLoS One. 2014;9(6):e99778. doi:10.1371/journal.pone.0099778
   Web of Science ®Google Scholar
• Andrykowski MA, Brady MJ, Henslee-Downey PJ. Psychosocial factors predictive of survival after allogeneic bone marrow transplantation for leukemia. Psychosom Med. 1994;56(5):432–439.
   Web of Science ®Google Scholar
• Knight JM, Lyness JM, Sahler OJZ, Liesveld JL, Moynihan JA. Psychosocial factors and hematopoietic stem cell transplantation: potential biobehavioral pathways. Psychoneuroendocrinology. 2013;38(11):2383–2393. doi:10.1016/j.psyneuen.2013.06.016
   PubMed Web of Science ®Google Scholar
• Cole SW, Sood AK. Molecular pathways: beta-adrenergic signaling in cancer. Clin Cancer Res. 2012;18(5):1201–1206. doi:10.1158/1078-0432.CCR-11-0641
   PubMed Web of Science ®Google Scholar
• Maestroni GJ. Neurohormones and catecholamines as functional components of the bone marrow microenvironment. Ann N Y Acad Sci. 2000;917(1):29–37.
   Google Scholar
• Barker LA, Dazin PF, Levine JD, Green PG. Sympathoadrenal‐dependent sexually dimorphic effect of nonhabituating stress on in vivo neutrophil recruitment in the rat. Br J Pharmacol. 2005;145(7):872–879. doi:10.1038/sj.bjp.0706257
   Web of Science ®Google Scholar
• Elenkov IJ, Iezzoni DG, Daly A, Harris AG, Chrousos GP. Cytokine dysregulation, inflammation and well-being. Neuroimmunomodulation. 2005;12(5):255–269. doi:10.1159/000087104
   PubMed Web of Science ®Google Scholar
• Miller AH, Ancoli-Israel S, Bower JE, Capuron L, Irwin MR. Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. J Clin Oncol. 2008;26(6):971. doi:10.1200/JCO.2007.15.2777
   PubMed Web of Science ®Google Scholar
• Wang XS, Shi Q, Williams LA, et al. Serum interleukin‐6 predicts the development of multiple symptoms at nadir of allogeneic hematopoietic stem cell transplantation. Cancer. 2008;113(8):2102–2109. doi:10.1002/cncr.23820
   Web of Science ®Google Scholar
• Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008;9(1):46. doi:10.1038/nrn2297
   PubMed Web of Science ®Google Scholar
• Andrykowski MA, Bishop MM, Hahn EA, et al. Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation. J Clin Oncol. 2005;23(3):599–608. doi:10.1200/JCO.2005.03.189
   PubMed Web of Science ®Google Scholar
• Brunoni AR, Machado-Vieira R, Sampaio-Junior B, et al. Plasma levels of soluble TNF receptors 1 and 2 after tDCS and sertraline treatment in major depression: results from the SELECT-TDCS trial. J Affect Disord. 2015;185:209–213. doi:10.1016/j.jad.2015.07.006
   Web of Science ®Google Scholar
• El-Jawahri A, Chen Y-B. Pleiotropic approach to graft-versus-host disease. J Clin Oncol. 2013;31(35):4462. doi:10.1200/JCO.2013.49.0219
   Web of Science ®Google Scholar
• Artz AS, Wickrema A, Dinner S, et al. Pretreatment C-reactive protein is a predictor for outcomes after reduced-intensity allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2008;14(11):1209–1216. doi:10.1016/j.bbmt.2008.08.004
   PubMed Web of Science ®Google Scholar
• Tavakoli-Ardakani M, Kheshti R, Maryam M. Effect of sertraline on complications and survival after hematopoietic stem-cell transplantation, a double-blind, placebo-controlled clinical study. Int J Hematol. 2017;106(6):832–841. doi:10.1007/s12185-017-2309-y
   Web of Science ®Google Scholar
• Sutcigil L, Oktenli C, Musabak U, et al. Pro-and anti-inflammatory cytokine balance in major depression: effect of sertraline therapy. Clin Dev Immunol. 2008;2007:6.
   Google Scholar
• Valkanova V, Ebmeier KP, Allan CL. CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies. J Affect Disord. 2013;150(3):736–744. doi:10.1016/j.jad.2013.06.004
   PubMed Web of Science ®Google Scholar